Vaginal Estrogen's hidden risk: blood clot clues sought in new study
NCT ID NCT07160504
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looks at whether low-dose vaginal estrogen, used to treat vaginal dryness in postmenopausal women, changes blood clotting factors. Researchers will take blood samples before and after 3 months of treatment in 90 women, some with a history of blood clots. The goal is to understand if this common treatment poses any clotting risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VAGINA ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Obstetrics and Gynecology, Aarhus University Hospital, Denmark
RECRUITINGAarhus N, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.